 |
|
Morbidity or Mortality Outcomes Associated With Prophylactic Salpingo-oophorectomy—Reply
|
|
| Since this article does not have an abstract, we have provided the first 68 words of the full text and any section headings. |
|
|
|
In Reply: Dr McCunniff raises an important point regarding the necessity of including other relevant outcomes, such as surgical morbidity and mortality, in a comprehensive evaluation of the risks and benefits of preventive surgery. Unfortunately, this information was not collected routinely for all patients in the current study. We intend to report the results for a smaller number of centers in a future study.
Financial Disclosures: None reported.
Steven A. Narod, MD
steven.narod@wchospital.ca
Amy Finch, MS
Centre for Research in Women's Health
Toronto-Sunnybrook Regional Cancer Center
Toronto, Ontario
Letters Section Editor: Robert M. Golub, MD, Senior Editor.
JAMA. 2006;296:2558.
RELATED LETTER
Morbidity or Mortality Outcomes Associated With Prophylactic Salpingo-oophorectomy
Dennis McCunniff
JAMA. 2006;296(21):2558.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation
Amy Finch, Mario Beiner, Jan Lubinski, Henry T. Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D. Foulkes, Charmaine Kim-Sing, Teresa Wagner, Nadine Tung, Fergus Couch, Dominique Stoppa-Lyonnet, Peter Ainsworth, Mary Daly, Barbara Pasini, Ruth Gershoni-Baruch, Charis Eng, Olufunmilayo I. Olopade, Jane McLennan, Beth Karlan, Jeffrey Weitzel, Ping Sun, Steven A. Narod, and for the Hereditary Ovarian Cancer Clinical Study Group
JAMA. 2006;296(2):185-192.
ABSTRACT
| FULL TEXT
|
